Institut Bergonie

Bordeaux, Cedex 33076

0 studies enrolling now · 3 studies all time

What they study most

Conventional Chondrosarcoma, HER2 Positive Breast Cancer, Metastatic Pancreatic Cancer, Pancreatic Cancer

Studies at this site

• A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer — Running, not enrolling
• Study of INBRX-109 in Conventional Chondrosarcoma — Running, not enrolling
• Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer — Stopped early